» Articles » PMID: 33211180

Diabetes Distress and Peripheral Neuropathy Are Associated with Medication Non-adherence in Individuals with Type 2 Diabetes in Primary Care

Overview
Journal Acta Diabetol
Specialty Endocrinology
Date 2020 Nov 19
PMID 33211180
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Psychosocial factors like diabetes distress and social support, as well as the presence of complications, affect an individual's self-management ability; however, their role in adherence behaviours is not yet clear. We examined the role of psychosocial factors and complications in non-adherence behaviours in individuals with diabetes in primary care.

Methods: Baseline survey with nine-month follow up through medical records of patients with type 2 diabetes attending primary care. Medication adherence and diabetes distress were assessed using Morisky Green Levine Medication Adherence Scale and Problem Areas in Diabetes, respectively. Appointment adherence was assessed through medical records.

Results: Of the 448 participants studied, 59.8% had medication non-adherence and 21.7% were non-adherent to scheduled appointments. PAID score (odds ratio (OR) 1.01, 95% confidence interval 1.00-1.03, p = 0.013), peripheral neuropathy (OR 1.99, 95%CI 1.18-3.37, p = 0.01), home glucose monitoring (OR 0.46, 95%CI 0.30-0.69, p < 0.001), HbA1c (OR 1.34, 95%CI 1.13-1.61, p = 0.001), and age (OR 0.96, 95%CI 0.93-0.98, p = 0.001) were associated with medication non-adherence. Indian ethnicity (OR 2.93, 95%CI 1.59-5.39, p = 0.001), secondary or higher education (OR 1.94, 95%CI 1.14-3.27, p = 0.014), and HbA1c (OR 1.38, 95%CI 1.18-1.63, p < 0.001) were associated with appointment non-adherence.

Conclusions: Non-adherence behaviours were prevalent and significantly associated with higher HbA1c. Medication non-adherence was more likely in younger individuals, those with higher diabetes distress or peripheral neuropathy. Appointment non-adherence was more likely in individuals of Indian ethnicity or those with higher education. Greater support for these groups may help improve adherence behaviours and outcomes.

Citing Articles

Factors associated with foot self-care behaviour and foot screening attendance in people with type 2 diabetes: a cross-sectional study in primary care.

Zhu X, Tjhin S, Goh L, de Roza J, Chan F, Yin R BMJ Open. 2024; 14(12):e088088.

PMID: 39740946 PMC: 11749657. DOI: 10.1136/bmjopen-2024-088088.


Impact of Patient Personality on Adherence to Oral Anticancer Medications: An Opportunity?.

Jafari M, Shahverdian A, Sadigh G, Van Etten R JMIR Cancer. 2024; 10:e57199.

PMID: 39475848 PMC: 11561440. DOI: 10.2196/57199.


Oral Diabetes Medication Videos on Douyin: Analysis of Information Quality and User Comment Attitudes.

Zhang B, Kalampakorn S, Powwattana A, Sillabutra J, Liu G JMIR Form Res. 2024; 8:e57720.

PMID: 39423367 PMC: 11530717. DOI: 10.2196/57720.


The role of emotion dysregulation in self-management behaviors among adults with type 2 diabetes.

Kollin S, Gratz K, Lee A J Behav Med. 2024; 47(4):672-681.

PMID: 38671288 PMC: 11291593. DOI: 10.1007/s10865-024-00483-5.


Effect of Food Consumption on the Pharmacokinetics, Safety, and Tolerability of Once-Daily Orally Administered Orforglipron (LY3502970), a Non-peptide GLP-1 Receptor Agonist.

Ma X, Liu R, Pratt E, Benson C, Bhattachar S, Sloop K Diabetes Ther. 2024; 15(4):819-832.

PMID: 38402332 PMC: 10951152. DOI: 10.1007/s13300-024-01554-1.


References
1.
Schectman J, Schorling J, Voss J . Appointment adherence and disparities in outcomes among patients with diabetes. J Gen Intern Med. 2008; 23(10):1685-7. PMC: 2533370. DOI: 10.1007/s11606-008-0747-1. View

2.
Holman R, Paul S, Bethel M, Matthews D, Neil H . 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med. 2008; 359(15):1577-89. DOI: 10.1056/NEJMoa0806470. View

3.
Giugliano D, Maiorino M, Bellastella G, Esposito K . Glycemic control in type 2 diabetes: from medication nonadherence to residual vascular risk. Endocrine. 2018; 61(1):23-27. DOI: 10.1007/s12020-017-1517-9. View

4.
Karter A, Parker M, Moffet H, Ahmed A, Ferrara A, Liu J . Missed appointments and poor glycemic control: an opportunity to identify high-risk diabetic patients. Med Care. 2004; 42(2):110-5. DOI: 10.1097/01.mlr.0000109023.64650.73. View

5.
McQueenie R, Ellis D, McConnachie A, Wilson P, Williamson A . Morbidity, mortality and missed appointments in healthcare: a national retrospective data linkage study. BMC Med. 2019; 17(1):2. PMC: 6329132. DOI: 10.1186/s12916-018-1234-0. View